Patents by Inventor Hans-Martin Dahse

Hans-Martin Dahse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL MACROLIDE ANTIBIOTICS
    Publication number: 20200231562
    Abstract: The present invention relates to a compound according to general formula (I), which exhibits bioactivity; methods for the production of the compound; to pharmaceutical compositions comprising one or more of the compound(s); and to the use of the compound(s) as a medicament.
    Type: Application
    Filed: July 7, 2015
    Publication date: July 23, 2020
    Inventors: Frank Surup, Heinrich Steinmetz, Kathrin Mohr, Konrad Viehrig, Rolf Müller, Markus Nett, Sebastian Schieferdecker, Hans-Martin Dahse, Michael Wolling, Andreas Kirschning
  • Chartreusin analogues
    Patent number: 9522930
    Abstract: The present invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same and to their use for the treatment of cancer and other diseases.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: December 20, 2016
    Assignee: LEIBNIZ-INSTITUT FÜR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE
    Inventors: Christian Hertweck, Hans-Martin Dahse, Nico Ueberschaar, Tom Bretschneider, Kirstin Scherlach, Mikko Metsae-Ketelae
  • NOVEL CHARTREUSIN ANALOGUES
    Publication number: 20150197539
    Abstract: The present invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same and to their use for the treatment of cancer and other diseases.
    Type: Application
    Filed: July 30, 2013
    Publication date: July 16, 2015
    Inventors: Christian Hertweck, Hans-Martin Dahse, Nico Ueberschaar, Tom Bretschneider, Kirstin Scherlach, Mikko Metsae-Ketelae
  • Benzopyranobenzothiazinones and their use as fungicides, antibiotics and antitumor agents
    Patent number: 9062077
    Abstract: This invention relates to the field of biologically active compounds and specifically to phaeofungins, of the general formula (I) or a pharmacologically acceptable salt, solvate, hydrate or a pharmacologically acceptable formulation thereof, pharmaceutical compositions comprising these compounds, methods for the production of the phaeofungins and their use as fungicide, antibiotic as well as antitumor agent.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: June 23, 2015
    Assignee: Leibniz-Institut fuer Naturstoff-Forschung und Infektionsbiologie E.V. Hans-Knoell-Institute (HKI)
    Inventors: Axel Brakhage, Hans-Martin Dahse, Christian Hertweck, Hans-Wilhelm Nuetzmann, Kirstin Scherlach
  • 4-amino-3-arylamino-6-arylpyrazolo[3,4-d) pyrimidine derivatives, methods for their preparation and their use as antiviral agents
    Patent number: 8962634
    Abstract: 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives of general formula (I), pharmaceutically acceptable salts thereof, method for preparation of the aforesaid compounds and their use as antiviral agents.
    Type: Grant
    Filed: June 20, 2007
    Date of Patent: February 24, 2015
    Assignee: Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG
    Inventors: Vadim Albertovitch Makarov, Peter Wutzler, Michaela Schmidtke, Hans-Martin Dahse
  • BENZOPYRANOBENZOTHIAZINONES AND THEIR USE AS FUNGICIDES, ANTIBIOTICS AND ANTITUMOR AGENTS
    Publication number: 20140315896
    Abstract: This invention relates to the field of biologically active compounds and specifically to phaeofungins, of the general formula (I) or a pharmacologically acceptable salt, solvate, hydrate or a pharmacologically acceptable formulation thereof, pharmaceutical compositions comprising these compounds, methods for the production of the phaeofungins and their use as fungicide, antibiotic as well as antitumor agent.
    Type: Application
    Filed: June 15, 2012
    Publication date: October 23, 2014
    Applicant: Leibniz-Institut fuer Naturstoff-Forschung und Infektionsbiologie E.V. Hans-Knoell-Institut (HKI)
    Inventors: Axel Brakhage, Hans-Martin Dahse, Christian Hertweck, Hans-Wilhelm Nuetzmann, Kirstin Scherlach
  • Closthioamides, compositions, and methods for treating bacterial or fungal infections or cancer
    Patent number: 8673980
    Abstract: This invention relates to the field of biologically active compounds and specifically to closthioamides, pharmaceutical compositions comprising these compounds, and their use as antibiotic, antifungal, and/or cytotoxic agent.
    Type: Grant
    Filed: November 2, 2010
    Date of Patent: March 18, 2014
    Assignee: Leibniz-Institut fuer Naturstoff-Forschung und Infektionsbiologie
    Inventors: Swantje Behnken, Hans-Martin Dahse, Christian Hertweck, Keishi Ishida, Thorger Lincke, Martin Roth, Florian Kloss
  • Closthioamides
    Publication number: 20120270940
    Abstract: This invention relates to the field of biologically active compounds and specifically to closthioamides, pharmaceutical compositions comprising these compounds, and their use as antibiotic, antifungal, and/or cytotoxic agent.
    Type: Application
    Filed: November 2, 2010
    Publication date: October 25, 2012
    Applicant: LELBUIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFE
    Inventors: Swantje Behnken, Hans-Martin Dahse, Christian Hertweck, Keishi Ishida, Thorger Lincke, Martin Roth, Florian Kloss
  • 4-Amino-3-Arylamino-6-Arylpyrazolo[3,4-D) Pyrimidine Derivatives, Methods for their Preparation and their Use as Antiviral Agents
    Publication number: 20100010018
    Abstract: 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives of general formula (I), pharmaceutically acceptable salts thereof, method for preparation of the aforesaid compounds and their use as antiviral agents.
    Type: Application
    Filed: June 20, 2007
    Publication date: January 14, 2010
    Inventors: Vadim Makarov, Peter Wutzler, Michaela Schmidtke, Hans-Martin Dahse
  • Method of treating infectious diseases with polysaccharide derivatives
    Patent number: 7297687
    Abstract: The present invention relates to a method of treating infectious diseases, that involves: (a) providing an alpha-glycosidically linked starch polysaccharide derivative; and (b) inhibiting the growth of an infectious disease by administering a composition comprising the alpha-glycosidically linked starch polysaccharide derivative. The alpha-glycosidically linked starch polysaccharide derivative represented by the following general formula I, in which: the alpha-glycosidically linked starch polysaccharide derivative has a degree of quaternary ammonium group substitution of from 0.4 to 2.
    Type: Grant
    Filed: January 10, 2003
    Date of Patent: November 20, 2007
    Assignee: Wolff Cellulosics GmbH Co. KG
    Inventors: Vera Haack, Thomas Heinze, Michaela Schmidtke, Ute Möllmann, Hans-Martin Dahse, Albert Härtl
  • Use of polysaccharide derivatives as anti-infective substances
    Publication number: 20050054609
    Abstract: The present invention relates to a method of treating infectious diseases, that involves: (a) providing an alpha-glycosidically linked starch polysaccharide derivative; and (b) inhibiting the growth of an infectious disease by administering a composition comprising the alpha-glycosidically linked starch polysaccharide derivative. The alpha-glycosidically linked starch polysaccharide derivative represented by the following general formula I, in which: the alpha-glycosidically linked starch polysaccharide derivative has a degree of quaternary ammonium group substitution of from 0.4 to 2.
    Type: Application
    Filed: January 10, 2003
    Publication date: March 10, 2005
    Inventors: Vera Haack, Thomas Heinze, Michaela Schmidtke, Ute Mollmann, Hans-Martin Dahse, Albert Hartl